Q32 Bio (QTTB) Other Working Capital Changes (2017 - 2026)
Q32 Bio's quarterly Other Working Capital Changes came in at -$302000.0 in Q1 2026, down 102.68% year-on-year from $11.2 million in Q1 2025, and up 79.04% quarter-over-quarter from -$1.4 million in Q4 2025.
Q32 Bio has reported Other Working Capital Changes for 10 years, with the latest figure at -$302000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Working Capital Changes fell 102.68% year-over-year to -$302000.0; the trailing twelve-month figure through Mar 2026 stood at -$2.0 million (down 325.91% YoY), and the FY2025 full-year result was -$1.9 million, down 586.96% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$302000.0, up from -$1.4 million in the prior quarter.
- The five-year high for Other Working Capital Changes was $6.9 million in Q2 2022, with the low at -$25.5 million in Q4 2023.
- Average Other Working Capital Changes over 5 years is -$2.0 million, with a median of -$336000.0 recorded in 2023.
- Year-over-year, Other Working Capital Changes plunged 896.45% in 2022 and jumped 5485.0% in 2024.
- Tracing QTTB's Other Working Capital Changes over 5 years: stood at -$2.8 million in 2022, then tumbled by 798.17% to -$25.5 million in 2023, then soared by 102.72% to $694000.0 in 2024, then tumbled by 307.64% to -$1.4 million in 2025, then soared by 79.04% to -$302000.0 in 2026.
- The last three Other Working Capital Changes figures came in at -$302000.0 (Q1 2026), -$1.4 million (Q4 2025), and -$35000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Q32 Bio | 162.94 Mn | 112.19 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -302,000.00 |
| Mar 31, 2026 | -302,000.00 |
| Dec 31, 2025 | -1.44 Mn |
| Dec 31, 2025 | -1.44 Mn |
| Sep 30, 2025 | -35,000.00 |
| Sep 30, 2025 | -35,000.00 |
| Jun 30, 2025 | -271,000.00 |
| Jun 30, 2025 | -271,000.00 |
| Mar 31, 2025 | -149,000.00 |
| Mar 31, 2025 | -149,000.00 |
| Dec 31, 2024 | 694,000.00 |
| Dec 31, 2024 | 694,000.00 |
| Sep 30, 2024 | -755,000.00 |
| Sep 30, 2024 | -755,000.00 |
| Jun 30, 2024 | 1.12 Mn |
| Jun 30, 2024 | 1.12 Mn |
| Mar 31, 2024 | -1.33 Mn |
| Mar 31, 2024 | -1.33 Mn |
| Dec 31, 2023 | -25.50 Mn |
| Dec 31, 2023 | -25.50 Mn |
| Sep 30, 2023 | -370,000.00 |
| Sep 30, 2023 | -370,000.00 |
| Jun 30, 2023 | 20,000.00 |
| Jun 30, 2023 | 20,000.00 |
| Dec 31, 2022 | -2.84 Mn |
| Dec 31, 2022 | -2.84 Mn |
| Sep 30, 2022 | -6.46 Mn |
| Sep 30, 2022 | -6.46 Mn |
| Jun 30, 2022 | 6.89 Mn |
| Jun 30, 2022 | 6.89 Mn |
| Mar 31, 2022 | -802,000.00 |
| Mar 31, 2022 | -802,000.00 |
| Dec 31, 2021 | 6.90 Mn |
| Dec 31, 2021 | 6.90 Mn |
| Sep 30, 2021 | -648,000.00 |
| Sep 30, 2021 | -648,000.00 |
| Jun 30, 2021 | -2.12 Mn |
| Jun 30, 2021 | -2.12 Mn |
| Mar 31, 2021 | 870,000.00 |
| Mar 31, 2021 | 870,000.00 |
| Dec 31, 2020 | -401,000.00 |
| Dec 31, 2020 | -401,000.00 |
| Sep 30, 2020 | -1.26 Mn |
| Sep 30, 2020 | -1.26 Mn |
| Jun 30, 2020 | 690,000.00 |
| Jun 30, 2020 | 690,000.00 |
| Mar 31, 2020 | -1.09 Mn |
| Mar 31, 2020 | -1.09 Mn |
| Dec 31, 2019 | -190,000.00 |
| Dec 31, 2019 | -190,000.00 |
| Sep 30, 2019 | -146,000.00 |
| Sep 30, 2019 | -146,000.00 |
| Jun 30, 2019 | 4.18 Mn |
| Jun 30, 2019 | 4.18 Mn |
| Mar 31, 2019 | -4.41 Mn |
| Mar 31, 2019 | -4.41 Mn |
| Dec 31, 2018 | -1.38 Mn |
| Dec 31, 2018 | -1.38 Mn |
| Sep 30, 2018 | 2.25 Mn |
| Sep 30, 2018 | 2.25 Mn |
| Jun 30, 2018 | 2.40 Mn |
| Jun 30, 2018 | 2.40 Mn |
| Mar 31, 2018 | 1.73 Mn |
| Mar 31, 2018 | 1.73 Mn |
| Dec 31, 2017 | 1.20 Mn |
| Dec 31, 2017 | 1.20 Mn |
| Sep 30, 2017 | -223,740.00 |
| Sep 30, 2017 | -223,740.00 |
| Jun 30, 2017 | 100,078.00 |
| Jun 30, 2017 | 100,078.00 |
| Mar 31, 2017 | 390,919.00 |
| Mar 31, 2017 | 390,919.00 |